{
    "clinical_study": {
        "@rank": "38692", 
        "brief_summary": {
            "textblock": "The purpose of this study is to characterize the effects of enadoline compared to\n      hydromorphone and butorphanol."
        }, 
        "brief_title": "Therapeutic Potential of Kappa-Opioids Against Cocaine - 1", 
        "completion_date": "December 1998", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        opiate experienced, healthy\n\n        Exclusion Criteria:\n\n        physical dependence on opioids, barbiturates or alcohol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "10", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000323", 
            "org_study_id": "NIDA-10753-1", 
            "secondary_id": "R01-10753-1"
        }, 
        "intervention_browse": {
            "mesh_term": "Analgesics, Opioid"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21224 6823"
                }, 
                "name": "Johns Hopkins University (BPRU) Bayview Campus"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Therapeutic Potential of Kappa-Opioids Against Cocaine", 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Sharon Walsh, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000323"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 1996", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "May 2004"
    }, 
    "geocoordinates": {
        "Johns Hopkins University (BPRU) Bayview Campus": "39.29 -76.612"
    }
}